Searching for the Optimal tDCS Target Combined With Peripheral Electrical Stimulation in Chronic Low Back Pain
Searching for the Optimal tDCS Target Combined With Peripheral Electrical Stimulation in Chronic Low Back Pain: a Protocol for a Pilot Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Palloma Andrade
- Phone Number: +5583993148319
- Email: pallomandrade@gmail.com
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age over 18 years;
- Diagnosis of chronic low back pain, lasting more than 6 months (The diagnosis of chronic lumbar pain will be based on clinical and neurophysiological criteria, according to the European Guidelines on Low Back Pain);
- Pain intensity of at least 4 in 10 in Visual Analogue Scale (VAS);
- Stable pharmacological treatment for at least one month before the study and throughout the study;
Exclusion Criteria:
- Intense pain from another origin, such as neuropathic pain;
- Alcohol or substance abuse;
- Associated diseases of the peripheral or central nervous system;
- Contraindications for non-invasive brain stimulation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: tDCS over M1 and PES
Anodic transcranial direct current stimulation (tDCS) over right primary motor cortex (M1) and PES (20Hz and 330ms) placed at the height between the T12 and S1 vertebrae in order to cover the entire lumbar area .
Duration: 30 minutes.
|
Patients will be submitted to 10 treatment sessions, five days a week, for 30 minutes, paired to the same PES protocol.
The participants will be positioned in ventral decubitus position.
The direct current (2 mA) will be transferred through a neuro-stimulator (TransCranial Technologies, Hong Kong, China), with the use of electrodes and 4x4 cm sponges moistened with 0.9% saline solution.
The anodic electrode will be placed on C3 to stimulate the left primary motor cortex according to the international 10-20 EEG system.
The reference electrode will be positioned in the supra orbital contralateral region.
For the PES, four self-adhesive electrodes with dimensions of 5 x 5 cm will be placed at the height between the T12 and S1 vertebrae in order to cover the entire lumbar area.
A 20Hz frequency and pulse duration of 330ms will be provided by means of two channels from an electro-stimulator (Neurodyn, Ibramed).
|
|
EXPERIMENTAL: tDCS over DLPFC and PES
Anodic transcranial direct current stimulation (tDCS) over left dorsolateral prefrontal cortex (DLPFC) and PES (20Hz and 330ms) placed at the height between the T12 and S1 vertebrae in order to cover the entire lumbar area .
Duration: 30 minutes.
|
Patients will be submitted to 10 treatment sessions, five days a week, for 30 minutes, paired to the same PES protocol.
The direct current (2 mA) will be transferred through a neuro-stimulator (TransCranial Technologies, Hong Kong, China), with the use of electrodes and 4x4 cm sponges moistened with 0.9% saline solution.
The anodic electrode will be placed on F3 to stimulate the left dorsolateral cortex according to the international 10-20 EEG system.
The reference electrode will be positioned in the supra orbital contralateral region.
For the PES, four self-adhesive electrodes with dimensions of 5 x 5 cm will be placed at the height between the T12 and S1 vertebrae in order to cover the entire lumbar area.
A 20Hz frequency and pulse duration of 330ms will be provided by means of two channels from an electro-stimulator (Neurodyn, Ibramed).
|
|
SHAM_COMPARATOR: Sham tDCS and PES
Sham tDCS and PES stimulation.
Anodic transcranial direct current stimulation (tDCS) over right primary motor cortex (M1) and PES (20Hz and 330ms) placed at the height between the T12 and S1 vertebrae in order to cover the entire lumbar area.
The currents will be turned off automatically after 30 seconds.
Duration: 30 minutes.
|
For sham tDCS and PES stimulation, patients will be submitted to 10 treatment sessions, five days a week, for 30 minutes.
The anodic electrode will be positioned on the left primary motor cortex, but the current will be turned off automatically after 30 seconds.
The reference electrode will be positioned in the supra orbital contralateral region.
For sham PES stimulations, four self-adhesive electrodes with dimensions of 5 x 5 cm will be placed at the height between the T12 and S1 vertebrae in order to cover the entire lumbar area.
A 20Hz frequency and pulse duration of 330ms will be provided by means of two channels from an electro-stimulator (Neurodyn, Ibramed), but the current will be turned off automatically after 30 seconds.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in pain severity
Time Frame: Baseline, endpoint (after 2 weeks) and the follow-up (after 1 month)
|
Pain severity will be assessed with Numerical Rating Scales (NRS), which refers to a subjective measure in which individuals classify their pain on an eleven-point numerical scale.
The scale is composed of 0 (no pain) to 10 (worst pain imaginable).
|
Baseline, endpoint (after 2 weeks) and the follow-up (after 1 month)
|
|
Changes in pain interference in activities of daily living
Time Frame: Baseline, endpoint (after 2 weeks) and the follow-up (after 1 month)
|
The Brief Pain Inventory (BPI) assesses multidimensional aspects of pain.
It includes 15 items that evaluate the existence, severity, location, functional interference, applied therapeutic strategies and effectiveness of pain treatment.
It is an instrument with adequate validity and reproducibility, commonly used in the evaluation of patients with chronic pain.
|
Baseline, endpoint (after 2 weeks) and the follow-up (after 1 month)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional disability associated with chronic low back pain measured by Roland Morris Disability Questionnaire (RMDQ)
Time Frame: Baseline, endpoint (after 2 weeks) and the follow-up (after 1 month)
|
The Roland Morris Disability Questionnaire (RMDQ) functional disability associated with chronic low back pain.
Composed of 24 questions, with a variation of scores between 0 and 24 points: Zero point corresponds to a person without complaints and the maximum value (24 points) to a patient with very severe limitations.
|
Baseline, endpoint (after 2 weeks) and the follow-up (after 1 month)
|
|
Quality of life (SF-36)
Time Frame: Baseline, endpoint (after 2 weeks) and the follow-up (after 1 month)
|
The Medical Outcomes Short-Form Health Survey (SF-36) - a general health assessment instrument, originally created in English, which is easy to administer and understand.
It consists of 36 questions, covering eight components, functional capacity, physical aspects, pain, general health status, vitality, social aspects, emotional aspects and mental health assessed by 35 questions and one more comparative question between current and health one year ago.
|
Baseline, endpoint (after 2 weeks) and the follow-up (after 1 month)
|
|
Electrical activity of lumbar/multifidus (ML) and transverse abdominal (TrA)
Time Frame: Baseline, endpoint (after 2 weeks) and the follow-up (after 1 month)
|
Surface Electromyography (EMGs) of the lumbar/multifidus (ML) and transverse abdominal (TrA) will be recorded using an 8-channel data acquisition system (model W4X8, Biometrics Ltd. , UK), bluetooth, with the following technical characteristics: hardware with 12-bit analog-to-digital (A/D) conversion board, 1000-fold gain amplifier, 20 to 500 Hz bandpass filter (2nd order Butterworth), common mode rejection ratio (RRMC) >100 dB, signal noise rate <3 mV RMS, 109 Ohms impedance, surface, bipolar, active, simple differential electrodes, 20-fold pre-amplification, reference electrode and DataLOG software for signal collection and analysis with 1000 Hz sampling frequency.
|
Baseline, endpoint (after 2 weeks) and the follow-up (after 1 month)
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Painmodulation
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.